Alongside healthcare, the beaver and maple syrup, Canadians enjoy drinking beer. Most Canadians mark special occasions with beer. Beer is a prominent drink in Canada, with over $9 billion in annual sales. People are not willing to settle for any kind of beer unless it is properly made, and has a fine taste. Learn more about Eli at releasefact.com.
Canadians have been crafting their beer making skills to ensure they make what suits their taste buds. Although big companies like Creemore, and Granville have been absorbed by multinational firms, small companies are selling their stock in the market. Absorption of big companies has not affected the market, since others are willing to take up the mantle. The Canadian beer is the fortune, and the exchange rate makes traveling to Canada appealing. Propeller Brewing Company is among the notable names in the Canadian brewing industry.
The list starts on the East Coast with Propeller leading the pack. It is a three-time World Beer Championship Winner and due to its strong caramel flavor, it is favored by many. It has a toned-down bitterness that makes it a good choice between Propeller lovers and haters. Another popular brand is the Pump, which is a fruit beer. It tastes like a juice than beer and it is preferred by new drinkers.
Eli Gershkovitch’s Input
Eli Gershkovitch is the founder of Streamworks Brew Pub. Eli has a Law degree from University of Toronto and he decided to pursue his passion in 1987. During an adventure in Europe, he tasted Belgian beer and he like the taste. From then, he was drawn to the idea of creating something unique and he started the journey. Eli Gershkovitch launched a law practice and then started researching on the brewery business. After a while, Eli Gershkovitch found the perfect location to set up a pub in Vancouver.
Although it took some time, his efforts bore fruits. When he was setting up the place, Eli Gershkovitch did not know that the place had a steam heat system that he could use in the brewing process. He experienced difficulties when trying to get liquor licenses, and was forced to wait for 14 months. Eli Gershkovitch opened the pub in 1995. Until now, Eli Gershkovitch is applauded for his input in the beer industry. Read more about his craft beers at The Bro Talk.
Dr. Mark Holterman is a well-accomplished professional in the medical field. He is a pediatric surgeon and educator. His parents were farmers, but they did not attend a college. He worked hard in academics, and they teachers suggested he should enroll at Yale University. He attended Yale University and majored in biology. He proceeded to University of Virginia (UVA) to be trained as a pediatric surgeon. Mark met a friend who had a passion for pediatric surgery. Her name is Ai-Xuan Le. She motivated Mark to pursue his career. They fell in love and got married in 1988.
Dr. Mark Holterman founded Mariam Global Health where he serves as the CEO. The organization is responsible for enhancing the application of technology in medical institutions. He has contributed a lot to the Illinois University as a full-time professor. He teaches pediatrics and surgery. He is also in charge of medical research in the institution. Dr. Mark Holterman was involved in the formation of Hannah Sunshine Foundation. The organization ensures that the people with chronic diseases can access medical services. He has conducted extensive research in new regenerative therapies and published several articles. He was honored with Innovative Research Award for the productive research that he has conducted in the medical field. Read more about Dr. Mark Holterman at Dial Dish.
Dr. Mark Holterman formed IPSAC-VN with the aim of improving medical services in Vietnam. The group after Mark and Ai-Xuan saw what Vietnamese were undergoing to before accessing the medical services. They visited the country in 2007.They discovered that the doctors and medical facilities were insufficient. As a result, they founded a nonprofit organization with the aim assisting Vietnamese to access improved medical services. Learn more about Dr. Mark Holterman’s profile at healthgrove.com.
Dr. Mark Holterman became successful due to the excellent educational credentials that he garnered. He majored in biology at Yale University. He obtained his Ph.D. at the University of Virginia. His experience as a pediatric surgeon spans over twenty years. Currently, he teaches medical students at University of Illinois. He has done extensive research in stem cell therapies. The outcome of the research has saved the lives of many people. He has also written articles on several topics such as bariatric surgery. The experience that he has gained in the medical field has been fundamental in the invention and innovation of medical technologies.
Lime Crime, an innovative cosmetics company, needed a new approach to expand its online presence into the Chinese market. There were, however, some major obstacles to achieving that dream.
The biggest obstacle was that China has a mandate that any cosmetics sold via wholesale had to be tested on animals, a condition that was not an option for this company that has based its marketing reputation on the fact that they are a vegan brand that does not engage in this practice. Therefore, the product needed to be shipped directly from the United States to avoid this requirement.
Other obstacles included complex transportation issues, managing international duties and taxes, and providing good customer service to people who spoke a foreign language. Another major issue was, as with any well-renowned brand, the practice of counterfeiting was rampant, in the case of one product over one million units just last year alone.
To overcome these obstacles, Kim Walls, Global General Manager for Lime Crime, went to the National Retail Federation’s (NRF) Shop.org Conference in Los Angeles. Her innovative approach was to partner with the Los Angeles based e-commerce fashion platform known as Revolve. Their brand was a good fit for her company because they were able to devise a plan to build a social media launch, giving existing fans of the product the opportunity to buy their favorites from the only source in the country that could guarantee the products were legitimate.
This “seed audience” could then use the social media venue to help expand the popularity of the brand name in China by purchasing through the well-known Revolve website. They were able to access the e-commerce hub two hours before the official launch, prompting word of mouth marketing at commuting time.
Revolve is now the major venue for selling LimeCrime to the Chinese market, a beautiful partnership for this unique line of beauty products.
Rapamycin is a substance that was discovered on Easter Island in 1972. Since that time it has been shown to have many medical uses. It’s been called a wonder drug by many in the medical industry. One of the foremost experts on Rapamycin is Dr. Mikhail Blagosklonny. He has researched the role it plays in curing cancer as well as its anti-aging properties. Know more about Mikhail at Philly Purge.
When a patient receives an organ transplant the response of the body is to reject it as foreign tissue. There are immunosuppressants that doctors prescribe to patients in order to prevent this from happening. Rapamycin is very effective in this role and has been prescribed to many patients. As it is antiproliferative it is also used to treat cancer. It can both enhance the body’s immune system and cause tumors to regress. This is the property of Rapamycin that Dr. Mikhail Blaggosklonny mainly focuses his research on.
Rapamycin is also showing promise in many other ways as well. Among these are treating Alzheimer’s disease, Muscular Dystrophy, and Systemic Lupus Erythematosus. Research on the effectiveness of Rapamycin treating these diseases is ongoing. Also ongoing research is being conducted by Dr. Mikhail Blagosklonny when it comes to Rapamycin’s anti-aging effects. His research has involved using it on mice. Rapamycin has helped these mice when it comes to tuberculosis. His next testing of Rapamycin will involve marmoset monkeys to see if it extends their lives. Read more on templeofthecave.com.
In addition to being a researcher, Dr. Mikhail Blagosklonny is also a professor and philanthropist. He teaches oncology at the Roswell Park Cancer Institute. Many of his students have decided to continue his research into Rapamycin as a cure for cancer and possible life extender. His work in this field is impactful and his research has been cited by other researchers many times. impactjournals.com is one particular research website where his work has garnered a lot of attention.
As a philanthropist Dr. Mikhail Blagosklonny wants cancer treatments to be both widespread and affordable to the masses. He thinks that everyone should have access to the latest medicine regardless of who much money they have. Currently, cancer treatment is extremely expensive and many people simply can’t afford it. He hopes that his research will lead to the costs coming down by a great deal.
Dr. Mikhail Blagosklonny works on targeted cancer drug therapies. The old way of treating cancer is very harmful and painful. It involves surgery, radiation, and chemotherapy all of which target every cell in the body rather than just the cancerous cells. It’s also not all that effective, at least as much as it could be. The types of cancer drugs he works on just destroy cancer cells only. This is a much healthier way of treating cancer. It is also much more effective. People who are treated with targeted cancer drugs also don’t have the same horrible side effects that people being treated the old way has, he says.
Learn more: https://classroomvoices.org/understanding-oncology-through-mikhail-blagosklonny/
Adam Milstein is an Israeli-American who has experienced a lot of life to arrive at a level where he is now in the position to be philanthropic helping many Jewish causes. Adam Milstein and his wife, Gila are founders of the Adam and Gila Milstein Family Foundation. Through the foundation they strive to strengthen the Israeli relationship with the U.S., the state of Israel and the Jewish People at large.
Adam Milstein was born in Haifa, Israel and with his wife now lives in Encino, California. He received his Bachelor of Science degree at the Israeli Institute of Technology in Israel and he received his Masters Degree in Business Administration at the University of Southern California in Los Angeles. He went on to excel in real estate investing through his company, Hager Pacific Properties. His success in real estate led to his philanthropic efforts today.
Hager Pacific Properties maintains a focus on buying and rehabilitating properties. The company buys multi-family properties, retail, industrial and office buildings. Adam Milstein obtained his interests in real estate from his father, Hillel. Hillel Milstein worked as a building framer in Israel. While Adam attended college, he helped his father expand the family’s real estate business in construction and development.
Having gotten an early introduction to the real estate fundamentals from his father, his first job in California was as a real estate salesman. There he gained inside knowledge of the marketplace in the U.S. He added what he learned in Israel and his business administration education. This gave Milstein all the tools he needed to aim high in real estate. His current and previous experience, plus his education paid off. As of 2009 it was estimated that he and his wife are now worth upwards of $147 million and more
Adam and Gila Milstein use their wealth to provide support to causes they believe in, such as programs that are tailored for Jewish children, adolescents, and adults. They also like to work with other philanthropic organizations to obtain shared goals. Adam Milstein and his foundation offer both funding and guidance to many groups that works to lift up and support positive Jewish and Israeli causes.
Scientists around the world do a lot of work, and the improvement in communications helped them reach out to their colleagues from the other side of the globe. The introduction of the internet also helped them to deliver information instantly, and it is helpful for those who are working in the field of medicine. Scientists keep on doing experiments day and night to discover breakthroughs, including the treatment and cure for fatal diseases, and the introduction of Oncotarget was a big help for them. Oncotarget is the only peer-reviewed online medical journal that was created by Mr. Andrei V. Gudkov and Mr. Blagosklonny, two of the most brilliant oncologists working at the Roswell Park Cancer Institute. Mr. Gudkov and Mr. Blagosklonny knew that the scientists would need a platform where they can share their discoveries, so the two decided to create Oncotarget and agreed that the platform should be online for easier access and sharing. Follow Oncotarget on Twitter.
Presently, the online medical journal releases two articles per week, and each article would go under extreme and strict reviews from individuals who are affiliated with the scientific community. Each article will be reviewed in detail, making sure that all the information is accurate and correct. After the review, it will be uploaded online for the scientists, and even the public, to see. Oncotarget has reached a global audience, and they are now considered as the most extensive online medical journal. Oncotarget initially focused on cancer-related information, but today, they are also including all information about rare and fatal diseases, publishing them for the use of the scientists.
Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/
Mikhail Blagosklonny and Andrei V. Gudkov are proud of their accomplishment, and they announced that Oncotarget would receive periodical updates to cater the needs of its users. Mikhail Blagosklonny and Andrei V. Gudkov stated that the online medical journal is the future of medicine, and they are hoping that with the introduction of the platform, more scientists will be able to share information with one another, and more diseases can be eradicated in the future because of the free flow of information. They are also hoping that Oncotarget will keep its present stature for years to come. Visit Oncotarget’s profile page at facebook.com
Jorge Moll, who specializes in cognitive neuroscience, has worked to go above and beyond with his work in neurology. Jorge Moll focuses on researching and publishing his findings on neural bases of behavior and moral cognition, neuroscience and social psychology, moral emotions and antisocial behavior. Moll has released an impressive 89 publications, including his most recent work Ventral Striatal Volumes Correlate with Individual’s Regret Related to Pleasure Rather than Duty.
Jorge Moll has an extensive educational background and specializes in cognitive neuroscience. Moll completed his medical degree in Neurology (1994) and medical residency (197) in from the Federal University of Rio de Janeiro. He continued to gain a Doctorate in Sciences, Ph.D. in Experimental Physiopathology and Human Physiology, from the University of Sao Paulo. He most recently completed his Post-doctorate in Science from the National Institutes of Health in 2007. Moll has been awarded the NIH Research Fellowship Award (2004-2007), the D’Or Institute for Research Education Reward, and the Visiting Scholar Award from Stanford University in 2015. Learn more about Jorge Moll at Google Scholar.
He is an Elected Affiliate Member of the Brazilian Academy of Sciences (2008) and an Elected Governor Board Member of the International Neuro-ethics Society (2012-13). Moll currently stands as the President-Director of the D’Or Institute for Research and Education and works as a member of the governing board for the institute in Rio de Janeiro, Brazil. He is also the Brazil Senior Researcher and Head of the Cognitive Neuroscience Unit and Neuroinformatic Workshop for the D’Or Institute for Research and Education. Jorge Moll has various society memberships; including, Brazilian Academy of Sciences, International Neuro-ethics Society, Organization for Human Brain Mapping, and Society for Neuroscience.
Moll contributes his expertise by reviewing journals and working as a member of the Editorial Board. He has recently reviewed Journal of Cognitive Neuroscience and the Social Neuroscience Newspaper and is involved in working with different publications to maintain professional research content. Jorge Moll has contributed greatly in the field of Neurology and continues to be involved in his research. Know more about Jorge at Crunchbase.
Glen Wakeman is an executive in the financial services sector. He worked in management for GE Capital for over 20 years where he was responsible for both P&L as well as business development. He is now the chief executive officer of a company he founded, LaunchPad Holdings LLC. Using his extensive experience he developed a platform on which entrepreneurs can create a comprehensive business plan. By creating a practical plan to guide them they are much more likely to find success with their new business. Read more on affiliatedork.com.
LaunchPad Holdings is the second company that Glen Wakeman has founded. While he was still working for GE Capital he established another company, Nova Four. This company was a business accelerator that provided a number of services to new companies in their startup stage. He mentored the entrepreneurs behind these companies and gave them strategic advice. He also gave them access to his network of venture capitalists and other lenders who could provide them with the funding to get their new idea off the ground.
Glen Wakeman writes a blog where he focuses on financial matters. This includes his thoughts on subjects such as international markets, including emerging markets. He also continues to mentor other business leaders. Among other companies he has mentored the executives of two companies, Dreamfunded and Sitter Bees.
What has happened in Puerto Rico by Hurricane Irma striking it in September is appalling. Recovery efforts have been hampered by a number of factors and many people, months later, still do not have electricity or access to clean water. Glen Wakeman has been a leader who has been pressuring corporations to assist in the efforts to help the people of Puerto Rico. One of the organizations that has been doing good work in Puerto Rico is The American Red Cross.
In addition to donating $1000 himself to the American Red Cross, Glen Wakeman has been trying to convince as many other top executives as he can to also financially contribute. He says that in an increasingly interconnected world he and other successful people have a moral duty to help those who at the present time have no way of taking care of themselves. Read more about Glen Wakeman at Premier Gazette.